Strattera (atomoxetine) is the first NON-stimulant approved for attention-deficit hyperactivity disorder (ADHD) in Canada

Strattera (atomoxetine) is the first NON-stimulant approved for attention-deficit hyperactivity disorder (ADHD) in Canada.

Unlike stimulants used for ADHD (Ritalin, Dexedrine), Strattera isn't a controlled drug and won't likely be abused.

Strattera blocks the reuptake of norepinephrine, which regulates attention, impulsivity, and activity.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote